JAYPIRCA® (PIRTOBRUTINIB) APPROVED IN CHINA FOR THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA

Reuters · 03/02 00:00

Please log in to view news